In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
All content for Genetic Sounds is the property of The European Society of Human Genetics and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
E6 – What is the next ethical frontier in genetics?
Genetic Sounds
41 minutes
2 years ago
E6 – What is the next ethical frontier in genetics?
In the final episode of our second series, we discuss the wide topic of “What is the next ethical frontier in genetics?”. Recorded with a live audience in Glasgow, Scotland. On the panel we have a wonderful range of guests including Professor Tara Clancy from The University of Manchester, Gemma Louise Chandratillake from the Institute of Continuing Education, and Masha Shabina, Assistant Professor in Privacy Law at Institute for International Research on Criminal Policy, Ghent, Belgium....
Genetic Sounds
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
